[Immune cytopenias in newborns]
- PMID: 11757274
[Immune cytopenias in newborns]
Abstract
Rhesus D haemolytic disease of the newborn (RH HDN) and neonatal PlA1 alloimmune thrombocytopenia (NAT) are the main immune cytopenias affecting fetal red blood cells or platelets through maternal antibodies. During RH HDN, fetal anaemia and neonatal hyperbilirubinaemia may progress, if untreated, towards fetal death and neonatal kernicterus. Likewise, during NAT, intracranial haemorrhage may occur antenally, at delivery or postnatally. Fetal and neonatal transfusion therapy, pre-term delivery, and intensive phototherapy avoid or greatly reduce the incidence of these complications. However, the best treatment of RH HDN is to prevent primary anti-D immunisation in Rh negative pregnant women through passive immunotherapy with Rh immune globulin.
Similar articles
-
[Treatment of a positive Rhesus D neonate born of a mother with idiopathic thrombopenic purpura with anti-D immunoglobulins (Rh O)].Arch Fr Pediatr. 1990 Feb;47(2):125-7. Arch Fr Pediatr. 1990. PMID: 2158285 French.
-
Transfusion medicine and the pregnant patient.Hematol Oncol Clin North Am. 2011 Apr;25(2):393-413, ix. doi: 10.1016/j.hoc.2011.02.002. Hematol Oncol Clin North Am. 2011. PMID: 21444037 Review.
-
[Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention].J Gynecol Obstet Biol Reprod (Paris). 1993;22(5):517-9. J Gynecol Obstet Biol Reprod (Paris). 1993. PMID: 8228016 French.
-
Severe hemolytic disease of the newborn from anti-e.J Perinatol. 2008 Mar;28(3):230-2. doi: 10.1038/sj.jp.7211897. J Perinatol. 2008. PMID: 18309317
-
Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).Iran J Immunol. 2008 Dec;5(4):189-200. Iran J Immunol. 2008. PMID: 19098362 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical